Patent FR849532A successfully refreshed from Google Patents.
Patent US3897431A successfully refreshed from Google Patents.
← Back to Patent Explorer
US3897431A Expired / Lapsed US ⏱️ 0.0 years remaining

2-{8 {60 -Alkoxy-arylmethyl{9 -2-imidazolines and -1,4,5,6-tetrahydropyrimidines

Assignee: STWB Inc
•
Filing: 1973-04-13
•
Granted: 1975-07-29
•
Expires: 1993-04-13
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract 2-( Alpha -(Lower-alkoxy)- Alpha -R1-Ar-methyl)-2-imidazolines, -1,4,5,6-tetrahydropyrimidines and -4,5,6,7-tetrahydro-1H-1,3diazepines, having pharmacological properties, e.g., hypoglycemic, diuretic, anti-inflammatory, are prepared by heating a 2-(lower-alkoxy)-2-Ar-alkanenitrile with an alkanediamine, wherein 2, 3 or 4 carbon atoms respectively intervene between the two amino groups, in the presence of a catalytic amount of carbon disulfide or hydrogen sulfide, where R1 is hydrogen, lower-alkyl or lower-alkenyl, Ar is phenyl, naphthyl, indanyl, biphenylyl, cyclohexenyl, cyclohexyl and phenyl substituted by from one to three substituents selected from lower-alkyl, lower-alkoxy, halo, trihalomethyl, loweralkylmercapto, lower-alkylsulfonyl, di-(lower-alkyl)amino, amino, hydroxy, nitro, hydroxyamino and benzyloxy. The intermediate 2(lower-alkoxy)-2-Ar-alkanenitriles are prepared preferably by first reacting an aldehyde of the formula Ar-CHO with a tri(lower-alkyl) orthoformate to form the aldehyde di-(lower-alkyl) acetal, reacting the latter with an acyl halide to form the corresponding Alpha -halo-Ar-methyl lower-alkyl ether and reacting said ether with an alkali cyanide to yield said intermediate nitrile.

Inventors

  • 👤 Denis M Bailey

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-30 14:17
CPC Classifications
C; C07; C07D; C07D239/00; C07D239/02; C07D239/06; C07C; C07C43/00; C07C43/02; C07C43/03; C07C43/14; C07C43/17; C07C43/174; C07C43/1742; C07C51/00; C07D233/00; C07D233/04; C07D233/20; C07D233/22

Claims Analysis

Total Claims: 23
Claim 1
Independent Claim 76 words
A COMPOUND HAVING THE FORMULA AR-C(-O-R)(-R'')-C<(=N-Y-NH-) WHEREIN R IS ALKYL HAVING FROM 2 TO 6 CARBON ATOMS R'' IS HYDROGEN OR LOWER-ALKYL, Y IS ALKYLENE OF 3-8 CARBON ATOMS IN WHICH 2 OR 3 CARBON ATOMS INTERVENE BETWEEN THE VALENCE LINKAGES AND AR IS PHENYL NAPTHYL INDANYL CYCLOHEXENYL CYCLOHEXYL AND PHENYL SUBSTITUTED BY TWO HALO SUBSTITUTENTS OR A SINGLE SUBSTITUTUENT SELETED FROM HALO NITRO, LOWER-ALKYL OR LOWER-ALKOXY SAID LOWER-ALKOXY BEING AT ONLY THE PARA-OSITION OF PHENYL.
Claim 2
Dependent Claim 76 words
A COMPOUND HAVING THE FORMULA AR-C(-O-R)(-R'')-C<(=N-Y-NH-) WHEREIN R IS ALKYL HAVING FROM 2 TO 6 CARBON ATOMS R'' IS HYDROGEN OR LOWER-ALKYL, Y IS ALKYLENE OF 3-8 CARBON ATOMS IN WHICH 2 OR 3 CARBON ATOMS INTERVENE BETWEEN THE VALENCE LINKAGES AND AR IS PHENYL NAPTHYL INDANYL CYCLOHEXENYL CYCLOHEXYL AND PHENYL SUBSTITUTED BY TWO HALO SUBSTITUTENTS OR A SINGLE SUBSTITUTUENT SELETED FROM HALO NITRO, LOWER-ALKYL OR LOWER-ALKOXY SAID LOWER-ALKOXY BEING AT ONLY THE PARA-OSITION OF PHENYL.
Claim 3
Dependent Claim 18 words
2-( Alpha -Alkoxy-Ar-methyl)-2-imidazoline according to claim 1 wherein two carbon atoms intervene between the valence linkages of alkylene.
Claim 4
Dependent Claim 18 words
2-( Alpha -Alkoxy-Ar-methyl)-1,4,5,6-tetrahydropyrimidine according to claim 1 wherein three carbon atoms intervene between the valence linkages of alkylene.
Claim 5
Dependent Claim 3 words
2-( Alpha -n-Propoxybenzyl)-2-imidazoline.
Claim 6
Dependent Claim 3 words
2-( Alpha -n-Propoxybenzyl)-2-imidazoline.
Claim 7
Dependent Claim 7 words
2-( Alpha -Ethoxy-3-flUorobenzyl)-1,4,5,6-tetrahydropyrimidine according to claim 3.
Claim 8
Dependent Claim 7 words
2-(2-Chloro- Alpha -ethoxybenzyl)-1,4,5,6-tetrahydropyrimidine according to claim 3.
Claim 9
Dependent Claim 7 words
2-(3-Fluoro- Alpha -ethoxybenzyl)-1,4,5,6-tetrahydro-5,5-dimethylpyrimidine according to claim 3.
Claim 10
Dependent Claim 7 words
2-(3-Chloro- Alpha -ethoxybenzyl)-1,4,5,6-tetrahydropyrimidine according to claim 3.
Claim 11
Dependent Claim 7 words
2-(4-Chloro- Alpha -ethoxybenzyl)-5-ethyl-1,4,5,6-tetrahydro-5-methylpyrimidine according to claim 3.
Claim 12
Dependent Claim 7 words
2-( Alpha -Ethoxybenzyl)-1,4,5,6-tetrahydro-5,5-dimethylpyrimidine according to claim 3.
Claim 13
Dependent Claim 7 words
2-(4-chloro- Alpha -ethoxybenzyl)-1,4,5,6-tetrahydro-5,5-dimethylpyrimidine according to claim 3.
Claim 14
Dependent Claim 9 words
2-( Alpha -Ethoxy- Alpha -ethylbenzyl)-1,4,5,6-tetrahydropyrimidine according to claim 3.
Claim 15
Dependent Claim 7 words
2-( Alpha -Ethoxybenzyl)-1,4,5,6-tetrahydropyrimidine according to claim 3.
Claim 16
Dependent Claim 7 words
2-(4-Chloro- Alpha -ethoxybenzyl)-1,4,5,6-tetrahydropyrimidine according to claim 3.
Claim 17
Dependent Claim 7 words
2-(2,6-Dichloro- Alpha -ethoxybenzyl)-1,4,5,6-tetrahydropyrimidine according to claim 3.
Claim 18
Dependent Claim 7 words
2-( Alpha -Ethoxy-(1-naphthyl)methyl)-1,4,5,6-tetrahydropyrimidine according to claim 3.
Claim 19
Dependent Claim 8 words
2-( Alpha -Ethoxybenzyl)-4,4(or 5,5)-dimethyl-2-imidazoline according to claim 2.
Claim 20
Dependent Claim 7 words
2-( Alpha -n-Butoxybenzyl)-1,4,5,6-tetrahydropyrimidine according to claim 3.
Claim 21
Dependent Claim 7 words
2-(4-Chloro- Alpha -ethoxybenzyl)-1,4,5,6-tetrahydro-5-methylpyrimidine according to claim 3.
Claim 22
Dependent Claim 7 words
2-( Alpha -Ethoxybenzyl)-1,4,5,6-tetrahydro-5-methylpyrimidine according to claim 3.
Claim 23
Dependent Claim 7 words
2-(3-Chloro- Alpha -ethoxybenzyl)-5-ethyl-1,4,5,6-tetrahydro-5-methylpyrimidine according to claim 3.

References Cited (Backward Citations)

US2919274A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1978-07-28 1979-01-27 1979-07-29 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1982-07-28 1983-01-27 1983-07-29 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1986-07-28 1987-01-27 1987-07-29 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag